Search
NEULASTIM 6 MG / 0.6 ML, Solution injectable
Details
| --- | Description |
|---|---|
| Pack | 1 seringue pré-remplie de 0,6 ml |
| Strength (Dosage) | 6 MG / 0.6 ML |
| Laboratory | AMAMYS PHARMA (Ex Saham pharma) |
| Ingredients | Pegfilgrastim |
| Therapeutic class | Antinéoplasiques et immunomodulateurs |
| ATC code | L03AA13 |
| PPH | $928.30 |
| PPV | $946.00 |
| Refundable | Yes |
| Refund base | $946.00 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | NEULASTIM est indiqué dans la réduction de la durée des neutropénies et de l’incidence des neutropénies fébriles chez les patients traités par une chimiothérapie cytotoxique pour une pathologie maligne (à l’exception des leucémies myéloïdes chroniques et des syndromes myélodysplasiques). |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem